WKN: | A407ZR |
ISIN: | NL0015001ZQ0 |
Land: | Niederlande |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Affimed-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 17. Juli 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2018 | 10,47 | 25,60 | 144,51% |
2 | 2020 | 23,95 | 47,45 | 98,12% |
3 | 2015 | 51,50 | 63,99 | 24,25% |
4 | 2021 | 47,45 | 47,72 | 0,57% |
5 | 2019 | 25,60 | 23,95 | -6,45% |
6 | 2025 | 1,22 | 0,97 | -20,49% |
7 | 2017 | 17,37 | 10,47 | -39,72% |
8 | 2023 | 11,26 | 4,76 | -57,73% |
9 | 2016 | 63,99 | 17,37 | -72,86% |
10 | 2024 | 4,76 | 1,22 | -74,37% |
11 | 2022 | 47,72 | 11,26 | -76,40% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2022 | 47,72 | 11,26 | -76,40% |
2 | 2024 | 4,76 | 1,22 | -74,37% |
3 | 2016 | 63,99 | 17,37 | -72,86% |
4 | 2023 | 11,26 | 4,76 | -57,73% |
5 | 2017 | 17,37 | 10,47 | -39,72% |
6 | 2025 | 1,22 | 0,97 | -20,49% |
7 | 2019 | 25,60 | 23,95 | -6,45% |
8 | 2021 | 47,45 | 47,72 | 0,57% |
9 | 2015 | 51,50 | 63,99 | 24,25% |
10 | 2020 | 23,95 | 47,45 | 98,12% |
11 | 2018 | 10,47 | 25,60 | 144,51% |